comparemela.com

Latest Breaking News On - New drug innovations - Page 1 : comparemela.com

Uni-Bio Science Group Limited Announces 2022 Annual Results

<b> Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved </b> <br/> <b>Expanding Portfolio with New Drug Innovations and Strategic R&amp;D Partnerships </b><b/> <br/> <br/> HONG KONG SAR - EQS Newswire - 27 March 2023 - A fully integrated biopharmaceutical company – <b>Uni-Bio Science Group Limited</b> ("Uni-Bio Science", together with its subsidiaries referred to as the "Group", stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2022 (the "Year").

Uni-Bio Science Group Limited: 2022 Annual Results -2-

Uni-Bio Science Group Limited: 2022 Annual Results

EQS Newswire / 27/03/2023 / 22:00 UTC+8Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved Expanding Portfolio with New Drug Innovations and Strategic R&amp;D Partnerships &nbsp;[27 March 2023 – Hong Kong] A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.